Core Viewpoint - Manulife Financial Corporation has announced a 10.2% increase in its quarterly common shareholders' dividend, raising it to $0.485 per share, effective March 19, 2026 [1]. Group 1: Dividend Announcement - The Board of Directors declared a dividend increase of 4.5 cents per share, resulting in a new dividend of $0.485 per share [1]. - The dividend is payable to shareholders of record as of February 25, 2026 [1]. - The company will purchase common shares on the open market for its Canadian and U.S. Dividend Reinvestment and Share Purchase Plans, with no applicable discounts on the purchase price [1]. Group 2: Company Overview - Manulife is a leading international financial services provider, operating under the name Manulife in Canada, Asia, and Europe, and as John Hancock in the United States [1]. - The company offers financial advice, insurance, and investment services, serving over 36 million customers globally [1]. - As of the end of 2024, Manulife had more than 37,000 employees and over 109,000 agents [1].

Core Insights - Manulife Financial Corporation reported record core earnings and insurance new business results for the year 2025, with a 10.2% increase in common share dividends [1][2] - The company announced a new Normal Course Issuer Bid program to repurchase up to 2.5% of outstanding common shares, expected to commence in late February 2026 [1][2] - The company achieved over 20% growth in new business CSM across all insurance segments, contributing to double-digit growth in CSM balance [1][3] Financial Performance - Core earnings for 2025 reached $7.5 billion, a 3% increase from 2024, with 4Q25 core earnings at $2.0 billion, up 5% year-over-year [3][4] - Net income attributed to shareholders for 2025 was $5.6 billion, a $0.2 billion increase compared to 2024, while 4Q25 net income was $1.5 billion, down $0.1 billion from 4Q24 [3][4] - The company reported a core EBITDA margin improvement of 260 basis points in Global WAM [1][2] Business Segments Performance - In Asia, net income attributed to shareholders increased by 22% to $2.1 billion, with core earnings up 18% [3][4] - Canada saw a net income decrease of 43% to $1.3 billion, while core earnings increased by 6% [3][4] - The U.S. segment reported a net income loss of $367 million, with core earnings down 22% [3][4] Strategic Initiatives - Manulife entered the Indian life insurance market through a joint venture with Mahindra, expanding its global footprint [1][2] - The company acquired 75% of Comvest Credit Partners, enhancing its private credit capabilities [2][3] - A new simplified lending suite was launched in Canada to streamline the lending experience for high-net-worth clients [2][3] Customer Engagement and Innovation - The company launched the Manulife Longevity Institute, investing $350 million through 2030 to promote healthier and financially secure lives [2][3] - Manulife deployed GenAI sales enablement solutions across multiple markets, enhancing client interactions and sales performance [2][3] - A strategic collaboration with Bupa International Limited was established to enhance healthcare access for customers in Hong Kong [2][3] Market Trends and Challenges - Global WAM experienced net outflows of $14.3 billion in 2025, compared to net inflows of $13.3 billion in 2024, driven by lower net sales through third-party intermediaries [4][5] - The company faced challenges in the U.S. segment due to unfavorable life insurance claims experience and lower investment spreads [3][4] - Despite macroeconomic uncertainties, the company remains focused on disciplined execution and sustainable growth [1][2]

Core Viewpoint - Manulife Financial Corporation intends to launch a Normal Course Issuer Bid (NCIB) to purchase up to 42 million common shares, approximately 2.5% of its outstanding shares, as part of its capital management strategy to enhance shareholder value [1]. Group 1: NCIB Details - The NCIB is subject to approval from the Toronto Stock Exchange (TSX) and has already received approval from the Office of the Superintendent of Financial Institutions (Canada) [1]. - As of January 31, 2026, Manulife had 1,676,743,043 common shares issued and outstanding [1]. - The bid period will commence after TSX acceptance and will last for up to one year, with all shares acquired under the NCIB to be cancelled [1]. Group 2: Purchase Mechanisms - Purchases may occur through TSX, New York Stock Exchange, and alternative trading systems at market prices or other permitted prices [1]. - Manulife may also acquire shares outside Canada and the U.S. and enter into derivative-based programs to support its purchase activities, subject to regulatory approval [1]. - The total number of shares purchased under the NCIB and other arrangements will not exceed 42 million [1]. Group 3: Previous NCIB Performance - Manulife's previous NCIB (2025 NCIB) commenced on February 24, 2025, allowing for the purchase of up to 51.5 million common shares, which was completed by January 22, 2026, at an average purchase price of $44.28 per share [1].

Company Overview - Manulife Financial Corporation (NYSE:MFC) is a global financial services provider operating in the Insurance and Annuity Products, Wealth & Asset Management, and Corporate & Other segments, with a presence in the United States, Asia, Canada, and internationally [4]. Analyst Ratings and Price Targets - Jefferies analyst John Aiken raised the price target on Manulife Financial Corporation from $39.64 to $42.58, maintaining a Buy rating, indicating a potential upside of 13.5% from current levels [1]. - Barclays analyst Alex Scott increased the price target from C$49 to C$52 while keeping a Hold rating, reflecting a slight downside of approximately 1% from current levels [2]. Industry Outlook - The life insurance sector is viewed with cautious optimism for 2026, supported by steady cash flow generation, solid capital levels, and ongoing industry consolidation, which help mitigate pressures from spread compression and higher technology investments [3].

Core Insights - Manulife Financial Corporation is considered one of the most undervalued Canadian stocks by hedge funds, with Barclays raising its price target to C$52 from C$49 while maintaining an Equal Weight rating [1] - The company reported a 16% year-over-year increase in EPS and a core ROE of 18.1% in Q3 2025, driven by record core earnings in its Asia, Canada, and Global WAM segments [2] - Manulife announced a 50:50 joint venture with Mahindra & Mahindra to enter the Indian life insurance market, leveraging local distribution and global expertise [2] Financial Performance - The Asia division achieved a notable 29% increase in core earnings, contributing significantly to overall performance [2] - Despite strong earnings, the Global WAM segment experienced $6.2 billion in net outflows, and the US segment saw a 20% decrease in core earnings due to unfavorable life insurance claims [3] Market Outlook - Barclays expressed a cautiously optimistic view on life insurers, highlighting that capital strength, cash flow, and consolidation are mitigating challenges such as spread compression and technology expenditures [1] - The company anticipates potential volatility in the Hong Kong market and expects a $25 million quarterly impact from regulatory changes to the Mandatory Provident Fund [3] Company Overview - Manulife Financial Corporation provides financial products and services internationally, operating through Wealth & Asset Management Businesses, Insurance & Annuity Products, and Corporate & Other segments [4]

股份發行人及根據《上市規則》第十九B章上市的香港預託證券發行人的證券變動月報表 截至月份: 2026年1月31日 狀態: 新提交 致：香港交易及結算所有限公司 公司名稱: 宏利金融有限公司 呈交日期: 2026年2月6日 I. 法定/註冊股本變動 FF301 FF301 | 1. 股份分類 | 普通股 | 股份類別 | 不適用 | 於香港聯交所上市 (註1) | 是 | | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | 00945 | 說明 | 普通股-不設上限及無面值 | | | | | | 法定/註冊股份數目 | | 面值 | 法定/註冊股本 | | 上月底結存 | | | | | | | 增加 / 減少 (-) | | | | | | | 本月底結存 | | | | | | | 2. 股份分類 | 優先股 | 股份類別 | 其他類別 (請註明) | 於香港聯交所上市 (註1) | 否 | | --- | --- | --- | --- | --- | --- | | 證券代號 (如上市) | N/A | 說明 | 第一類優先股 - 不設上限及無面值 ...

Core Viewpoint - Momentum investing focuses on following a stock's recent price trends, aiming to buy high and sell higher, with the expectation that established trends will continue [1] Company Overview: Manulife Financial (MFC) - Manulife Financial currently holds a Momentum Style Score of B, indicating potential as a solid momentum pick [3][12] - The company has a Zacks Rank of 2 (Buy), which is associated with strong historical performance [4] Performance Metrics - Over the past week, MFC shares increased by 3.14%, outperforming the Zacks Insurance - Life Insurance industry, which rose by 1.59% [6] - In the last quarter, MFC shares rose by 8.86%, and over the past year, they increased by 25.48%, while the S&P 500 only moved 1.9% and 15.32%, respectively [7] - The average 20-day trading volume for MFC is 1,740,134 shares, indicating a bullish sign with rising stock prices [8] Earnings Outlook - In the past two months, two earnings estimates for MFC have been revised upwards, increasing the consensus estimate from $2.86 to $2.96 [10] - For the next fiscal year, two estimates have also moved upwards, with no downward revisions during the same period [10]

宏利金融有限公司 董事會會議通告 本公司謹定於加拿大多倫多舉行董事會會議: 多倫多，二零二六年一月二十七日 香港時間: 二零二六年二月十二日星期四 截至二零二五年十二月三十一日止年度的財務報表將於會議上提呈董事會批准。 宏利金融有限公司 助理公司秘書 Scott MacIntosh 二零二六年二月十一日星期三 (多倫多時間) ...

Group 1 - Manulife Financial Corporation (MFC) has been upgraded to Outperformer by CIBC, with a price target increase from C$50 to C$58, reflecting steady progress towards medium-term goals and potential for higher stock multiples over time [2] - The core life insurance business of Manulife is performing well, supported by higher yields on longer-duration assets, which aids in aligning long-term liabilities with cash-generating assets [3] - The wealth management segment is experiencing growth, particularly in Asia, where significant investments have been made, contributing to the long-term investment case for the company [4] Group 2 - Manulife operates globally under the Manulife brand in Canada, Asia, and Europe, and under the John Hancock name in the United States, providing insurance and financial advice [4]

Core Viewpoint - The investment strategy is shifting towards quality value stocks, particularly in the industrial sector, as earnings growth expectations remain strong for 2026 [1]. Industrial Sector - The industrial sector is favored due to higher return on equity and solid demand, with earnings growth projected at 16% [2]. - Industrial companies are expected to benefit significantly from accelerated depreciation policies, which will stimulate tech capital expenditures [3]. - The aerospace and defense industries are experiencing robust demand, indicating a positive outlook for these sectors [6]. Defense Stocks - Defense stocks have outperformed most sectors, with Boeing's stock rising 40% since November [4]. - Investors are advised to embrace geopolitical risks through investments in defense stocks and metals, rather than attempting to trade on geopolitical headlines [5]. Mid and Small Caps - Mid-cap stocks are gaining attention, with a notable participation in the market, contrasting with the focus on mega-cap tech stocks [7]. - Small and mid-cap stocks are showing strong earnings momentum, particularly in the industrials and regional banks [9]. Regional Banks - Regional banks are experiencing double-digit earnings growth and active M&A activity, although they face potential headline risks and regulatory challenges [10]. Economic Outlook - The economy is showing signs of good growth with controlled inflation, countering fears of stagflation [12]. - Economic indicators such as PMI and ISM are expected to remain above 50, signaling positive growth [13]. - Inflation is projected to moderate into 2026, with housing prices stabilizing and energy prices remaining manageable [14].